These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31701074)

  • 1. Incidence of and Risk Factors for Hepatic Encephalopathy in a Population-Based Cohort of Americans With Cirrhosis.
    Tapper EB; Henderson JB; Parikh ND; Ioannou GN; Lok AS
    Hepatol Commun; 2019 Nov; 3(11):1510-1519. PubMed ID: 31701074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.
    Tapper EB; Aberasturi D; Zhao Z; Hsu CY; Parikh ND
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1397-1405. PubMed ID: 32363684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Incidence of Hepatic Encephalopathy and Higher Odds of Resolution Associated With Eradication of HCV Infection.
    Tapper EB; Parikh ND; Green PK; Berry K; Waljee AK; Moon AM; Ioannou GN
    Clin Gastroenterol Hepatol; 2020 May; 18(5):1197-1206.e7. PubMed ID: 31589975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial and ethnic disparities in rifaximin use and subspecialty referrals for patients with hepatic encephalopathy in the United States.
    Tapper EB; Essien UR; Zhao Z; Ufere NN; Parikh ND
    J Hepatol; 2022 Aug; 77(2):377-382. PubMed ID: 35367057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of, Risk Factors for, and Outcomes After Ascites in a Population-Based Cohort of Older Americans.
    Tapper EB; Zhao Z; Mazumder N; Parikh ND
    Dig Dis Sci; 2022 Nov; 67(11):5327-5335. PubMed ID: 35262903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and the progression of non-alcoholic fatty liver disease to decompensated cirrhosis: a retrospective cohort study.
    O'Beirne J; Skoien R; Leggett BA; Hartel GF; Gordon LG; Powell EE; Valery PC
    Med J Aust; 2023 Oct; 219(8):358-365. PubMed ID: 37749902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
    Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
    Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and Bedside Predictors of the First Episode of Overt Hepatic Encephalopathy in Patients With Cirrhosis.
    Tapper EB; Zhao L; Nikirk S; Baki J; Parikh ND; Lok AS; Waljee AK
    Am J Gastroenterol; 2020 Dec; 115(12):2017-2025. PubMed ID: 32773463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.
    Dam G; Vilstrup H; Watson H; Jepsen P
    Hepatology; 2016 Oct; 64(4):1265-72. PubMed ID: 27474889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcohol Abstinence Improves Prognosis Across All Stages of Portal Hypertension in Alcohol-Related Cirrhosis.
    Hofer BS; Simbrunner B; Hartl L; Jachs M; Bauer DJM; Balcar L; Paternostro R; Schwabl P; Semmler G; Scheiner B; Staettermayer AF; Trauner M; Mandorfer M; Reiberger T
    Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2308-2317.e7. PubMed ID: 36481475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis.
    Pearson MM; Kim NJ; Berry K; Moon AM; Su F; Vutien P; Green PK; Williams EC; Ioannou GN
    Hepatol Commun; 2021 Dec; 5(12):2080-2095. PubMed ID: 34601829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding.
    Hung TH; Lee HF; Tseng CW; Tsai CC; Tsai CC
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):353-359. PubMed ID: 29551615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohort.
    Dai R; Sag AA; Martin JG; Befera NT; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY; Muir AJ; Ronald J
    Clin Imaging; 2021 Sep; 77():187-192. PubMed ID: 33940357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis.
    Vilar-Gomez E; Calzadilla-Bertot L; Wong VW; Castellanos M; Aller-de la Fuente R; Eslam M; Wong GL; George J; Romero-Gomez M; Adams LA
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):136-145.e6. PubMed ID: 32389886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors.
    Williams S; Louissaint J; Nikirk S; Bajaj JS; Tapper EB
    United European Gastroenterol J; 2021 Mar; 9(2):193-202. PubMed ID: 33226300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis.
    Fallahzadeh MA; Asrani SK; Tapper EB; Saracino G; Rahimi RS
    World J Clin Cases; 2022 Aug; 10(23):8097-8106. PubMed ID: 36159543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis.
    Tapper EB; Parikh ND; Sengupta N; Mellinger J; Ratz D; Lok AS; Su GL
    Hepatology; 2018 Oct; 68(4):1498-1507. PubMed ID: 29091289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis.
    Moon AM; Jiang Y; Rogal SS; Tapper EB; Lieber SR; Barritt AS
    Aliment Pharmacol Ther; 2020 Mar; 51(6):652-660. PubMed ID: 31960985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ammonia levels on outcome in clinically stable outpatients with advanced chronic liver disease.
    Balcar L; Krawanja J; Scheiner B; Paternostro R; Simbrunner B; Semmler G; Jachs M; Hartl L; Stättermayer AF; Schwabl P; Pinter M; Szekeres T; Trauner M; Reiberger T; Mandorfer M
    JHEP Rep; 2023 Apr; 5(4):100682. PubMed ID: 36873421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.
    Nardelli S; Gioia S; Ridola L; Farcomeni A; Merli M; Riggio O
    Hepatology; 2019 Aug; 70(2):640-649. PubMed ID: 30289992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.